These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10806599)

  • 21. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
    Potkin SG; Preskorn S; Hochfeld M; Meng X
    J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
    Makaryus AN; Byrns K; Makaryus MN; Natarajan U; Singer C; Goldner B
    South Med J; 2006 Jan; 99(1):52-6. PubMed ID: 16466123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily dosing of vismodegib to steady state does not prolong the QTc interval in healthy volunteers.
    Graham RA; Chang I; Jin JY; Wang B; Dufek MB; Ayache JA; Ezzet F; Zerivitz K; Low JA; Dresser MJ
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):83-9. PubMed ID: 23107871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of the QT-corrected interval during dobutamine stress echocardiography: a marker for ischemia.
    Vora T; Pendyala P; Schünemann H; López-Candales A
    Coron Artery Dis; 2003 May; 14(3):233-7. PubMed ID: 12702927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in cardiac repolarization following intravenous sotalol administration.
    Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
    Malik M; Hnatkova K; Batchvarov V
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.
    Parkinson J; Visser SA; Jarvis P; Pollard C; Valentin JP; Yates JW; Ewart L
    J Pharmacol Toxicol Methods; 2013; 68(3):357-66. PubMed ID: 23567074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
    Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
    J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of baseline measurement on the change from baseline in QTc intervals.
    Tian H; Natarajan J
    J Biopharm Stat; 2008; 18(3):542-52. PubMed ID: 18470762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study.
    White PF; Song D; Abrao J; Klein KW; Navarette B
    Anesthesiology; 2005 Jun; 102(6):1101-5. PubMed ID: 15915020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
    Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
    Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).
    Chiang AY; Bass AS; Cooper MM; Engwall MJ; Menton RG; Thomas K
    J Pharmacol Toxicol Methods; 2007; 56(2):95-102. PubMed ID: 17588780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of six commonly used QT correction models and their parameter estimation methods.
    Wang D; Taubel J; Arezina R
    J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 summary of plasma concentration-QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML.
    Blotner S; Chen LC; Ferlini C; Zhi J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):597-607. PubMed ID: 29392451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for QTc interval prolongation.
    Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.